N-{[3-(10-ethyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide
Chemical Structure Depiction of
N-{[3-(10-ethyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide
N-{[3-(10-ethyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide
Compound characteristics
Compound ID: | G946-0183 |
Compound Name: | N-{[3-(10-ethyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide |
Molecular Weight: | 470.55 |
Molecular Formula: | C26 H22 N4 O3 S |
Smiles: | CCN1C(c2ccccc2Sc2cc(ccc12)c1nc(CNC(Cc2ccccc2)=O)on1)=O |
Stereo: | ACHIRAL |
logP: | 5.1638 |
logD: | 5.1638 |
logSw: | -4.9379 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 70.94 |
InChI Key: | QIIWMNFMBLVOFA-UHFFFAOYSA-N |